奥利斯特
肥胖
脂肪酶
药品
药理学
医学
体内
副作用(计算机科学)
生物
酶
生物信息学
内科学
减肥
生物技术
生物化学
计算机科学
程序设计语言
作者
Metín Bülbül,Selin Çokdinleyen
标识
DOI:10.1002/slct.202401091
摘要
Abstract Obesity is a condition caused by abnormal fat accumulation. The prevalence of obesity and related diseases is increasing globally, and efforts to find solutions are ongoing. In addition to diet, exercise, and surgery, drug therapy is recommended for individuals seeking a solution. Current anti‐obesity drugs target central and peripheral pathways. However, drugs targeting the central nervous system have serious side effects. Therefore, one of the approaches in the treatment of obesity is to inhibit pancreatic lipase (PL), which acts on peripheral pathways. Currently, the only clinically approved PL inhibitor is Orlistat, but this semi‐synthetic drug has also been associated with unwanted side effects. Recently, there has been extensive research on natural sources and natural products derived from these sources as potential lipase inhibitors with fewer side effects. This article reviews recent in vitro studies on inhibiting the PL enzyme by extracts from plants, fungi, and algae, as well as natural products derived from these extracts. In addition, the review presents recent molecular docking and in vivo studies demonstrating potential natural PL inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI